Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/185358
Quantitative informant- and self-reports of subjective cognitive decline predict amyloid beta PET outcomes in cognitively unimpaired individuals independently of age and APOE ε4
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Introduction: Amyloid beta (Aβ) pathology is an Alzheimer's disease early hallmark. Here we assess the value of longitudinal self- and informant reports of cognitive decline to predict Aβ positron emission tomography (PET) outcome in cognitively unimpaired middle-aged individuals. Methods: A total of 261 participants from the ALFA+ study underwent [18F]flutemetamol PET and Subjective Cognitive Decline Questionnaire (SCD-Q) concurrently, and 3 years before scan. We used logistic regressions to evaluate the ability of SCD-Q scores (self and informant) to predict Aβ PET visual read, and repeated analysis of variance to assess whether changes in SCD-Q scores relate to Aβ status. Results: Self-perception of decline in memory (odds ratio [OR] = 1.2), and informant perception of executive decline (OR = 1.6), increased the probability of a positive scan. Informant reports 3 years before scanning predicted Aβ PET outcome. Longitudinal increase of self-reported executive decline was predictive of Aβ in women (P = .003). Discussion: Subjective reports of cognitive decline are useful to predict Aβ and may improve recruitment strategies.
Matèries (anglès)
Citació
Citació
SÁNCHEZ BENAVIDES, Gonzalo, SALVADÓ, Gemma, ARENAZA URQUIJO, Eider m., GRAU RIVERA, Oriol, SUÁREZ CALVET, Marc, MILÀ ALOMÀ, Marta, GONZÁLEZ DE ECHÁVARRI, José m., MINGUILLÓN, Carolina, CROUS BOU, Marta, NIÑEROLA BAIZÁN, Aida, PERISSINOTTI, Andrés, GISPERT, Juan domingo, MOLINUEVO, José luis, ALFA Study. Quantitative informant- and self-reports of subjective cognitive decline predict amyloid beta PET outcomes in cognitively unimpaired individuals independently of age and APOE ε4. _Alzheimer's & Dementia: Diagnosis_. Assessment & Disease Monitoring (DADM). Vol. 2020, núm. 12, pàgs. 1. [consulta: 21 de gener de 2026]. ISSN: 2352-8729. [Disponible a: https://hdl.handle.net/2445/185358]